Co-Occurring Disorders: When Addiction and Mental Illness Show Up Together

The most common mistake in treating addiction is treating it alone.

According to the Substance Abuse and Mental Health Services Administration, approximately 9.2 million adults in the United States have both a mental health disorder and a substance use disorder — what clinicians call co-occurring disorders, or dual diagnosis. Yet the majority of treatment programs are still designed to treat one or the other, not both simultaneously.

The consequences of that gap are significant. When a mental health condition drives substance use and goes untreated, relapse is almost inevitable. When substance use masks or worsens a psychiatric condition and the psychiatric component goes unaddressed, recovery stalls. The two conditions feed each other in ways that require both to be treated at once.

Why Co-Occurring Disorders Are So Frequently Missed

There are several reasons co-occurring disorders are underdiagnosed. First, many psychiatric symptoms are temporarily masked by active substance use — or temporarily worsened by it — making accurate assessment difficult until there is a period of sobriety. A person who presents with severe depression during active alcohol use may have a primary depressive disorder, alcohol-induced depressive disorder, or both. You often can't tell until they've been sober for several weeks.

Second, the treatment system itself has historically been fragmented along these lines, with substance use treatment programs and mental health programs operating separately, with different funding streams, different regulatory environments, and different clinical cultures. Patients fell into the gap between systems — too mentally ill for most addiction programs, too addicted for most mental health programs.

Third, the stigma associated with both conditions compounds reluctance to disclose fully, making complete clinical pictures harder to obtain.

The Self-Medication Hypothesis: Real, But Incomplete

One of the most common frameworks families use to understand co-occurring disorders is the self-medication hypothesis — the idea that their loved one uses substances to manage the symptoms of an underlying mental health condition. There is real research supporting this: people with PTSD, bipolar disorder, anxiety disorders, and schizophrenia all show elevated rates of substance use, and the neurological rationale for why is well-established.

But the relationship is bidirectional. Substance use also causes, worsens, and sustains psychiatric symptoms. Heavy alcohol use causes depression. Stimulant use causes anxiety and, in some cases, psychosis. Cannabis use is now clearly linked to elevated psychosis risk. The self-medication framing, while useful for building empathy, can inadvertently suggest that treating the mental health condition will resolve the substance use problem — which is often not the case.

Why Sequential Treatment Fails

For years, the standard approach was sequential treatment: address the substance use first, then address the mental health condition, or vice versa. The logic made intuitive sense. The outcomes didn't support it. Research consistently shows that treating co-occurring disorders sequentially produces worse outcomes than integrated treatment — in which both conditions are addressed simultaneously by a coordinated team.

Integrated Dual Diagnosis Treatment (IDDT), developed through the Dartmouth Psychiatric Research Center and extensively studied by Robert Drake and colleagues, is the evidence-based standard for this population. IDDT combines motivational interviewing, cognitive behavioral therapy, pharmacotherapy when appropriate, family education, and supported employment into a single, coordinated care framework. The research on IDDT demonstrates significantly better outcomes on substance use, psychiatric symptoms, and functional recovery compared to parallel or sequential approaches.

DBT and ACT: Evidence-Based Therapies That Serve This Population Well

Dialectical Behavior Therapy (DBT), originally developed by Marsha Linehan for borderline personality disorder, has become one of the most widely used and well-researched treatments for co-occurring disorders. DBT's emphasis on distress tolerance, emotional regulation, mindfulness, and interpersonal effectiveness addresses many of the underlying vulnerabilities that drive both psychiatric symptoms and substance use. Linehan's own research on DBT adapted for substance use disorders showed significant reductions in both drug use and suicidal behavior.

Acceptance and Commitment Therapy (ACT) offers a complementary framework — helping individuals develop psychological flexibility, observe their thoughts and feelings without being controlled by them, and commit to value-driven action even in the presence of distress. For people who have spent years using substances to escape internal experience, ACT's approach to building tolerance for difficult emotions is particularly relevant.

What to Look for in Dual Diagnosis Treatment

Not every program that calls itself "dual diagnosis capable" actually provides integrated treatment. When evaluating programs for someone with co-occurring disorders, the right questions to ask include: Does the program have psychiatric staff on-site, or only on consultation? Is the substance use treatment and mental health treatment delivered by the same team or by separate providers in separate tracks? Does the program have experience with the specific psychiatric presentation involved — trauma, psychosis, bipolar disorder, severe depression? Is medication management integrated into the treatment plan from day one?

These distinctions are the difference between a program that can hold this complexity and one that will discharge a person the first time psychiatric symptoms complicate the expected course. That's the work of treatment placement: not just finding a bed, but finding the right clinical environment for the actual presentation.

If you're concerned a loved one may have co-occurring disorders, contact us for a confidential consultation.